Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Multi-modal Cohort Study of Local Treatment-related Toxicities and Quality of Life in Chinese Breast Cancer Patients (PERSEVERE)

NCT07010939 is registered in ClinicalTrials.gov with FangYi as lead sponsor.

NCT NCT07010939
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07010939 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Multi-modal Cohort Study of Local Treatment-related Toxicities and Quality of Life in Chinese Breast Cancer Patients (PERSEVERE)
Lead sponsor
FangYi
Phase
Observational
Overall status
Recruiting
Start date
April 7, 2025
Completion date
December 31, 2028
Enrollment
3,000 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast diseases, breast neoplasms, quality of life (qol), toxicities